以人类与人工智能合作为基准,开发通用证据评估工具。

IF 7.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Journal of Clinical Epidemiology Pub Date : 2024-09-12 DOI:10.1016/j.jclinepi.2024.111533
Tim Woelfle , Julian Hirt , Perrine Janiaud , Ludwig Kappos , John P.A. Ioannidis , Lars G. Hemkens
{"title":"以人类与人工智能合作为基准,开发通用证据评估工具。","authors":"Tim Woelfle ,&nbsp;Julian Hirt ,&nbsp;Perrine Janiaud ,&nbsp;Ludwig Kappos ,&nbsp;John P.A. Ioannidis ,&nbsp;Lars G. Hemkens","doi":"10.1016/j.jclinepi.2024.111533","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Objective</h3><div>It is unknown whether large language models (LLMs) may facilitate time- and resource-intensive text-related processes in evidence appraisal. The objective was to quantify the agreement of LLMs with human consensus in appraisal of scientific reporting (Preferred Reporting Items for Systematic reviews and Meta-Analyses [PRISMA]) and methodological rigor (A MeaSurement Tool to Assess systematic Reviews [AMSTAR]) of systematic reviews and design of clinical trials (PRagmatic Explanatory Continuum Indicator Summary 2 [PRECIS-2]) and to identify areas where collaboration between humans and artificial intelligence (AI) would outperform the traditional consensus process of human raters in efficiency.</div></div><div><h3>Study Design and Setting</h3><div>Five LLMs (Claude-3-Opus, Claude-2, GPT-4, GPT-3.5, Mixtral-8x22B) assessed 112 systematic reviews applying the PRISMA and AMSTAR criteria and 56 randomized controlled trials applying PRECIS-2. We quantified the agreement between human consensus and (1) individual human raters; (2) individual LLMs; (3) combined LLMs approach; (4) human–AI collaboration. Ratings were marked as deferred (undecided) in case of inconsistency between combined LLMs or between the human rater and the LLM.</div></div><div><h3>Results</h3><div>Individual human rater accuracy was 89% for PRISMA and AMSTAR, and 75% for PRECIS-2. Individual LLM accuracy was ranging from 63% (GPT-3.5) to 70% (Claude-3-Opus) for PRISMA, 53% (GPT-3.5) to 74% (Claude-3-Opus) for AMSTAR, and 38% (GPT-4) to 55% (GPT-3.5) for PRECIS-2. Combined LLM ratings led to accuracies of 75%–88% for PRISMA (4%–74% deferred), 74%–89% for AMSTAR (6%–84% deferred), and 64%–79% for PRECIS-2 (29%–88% deferred). Human–AI collaboration resulted in the best accuracies from 89% to 96% for PRISMA (25/35% deferred), 91%–95% for AMSTAR (27/30% deferred), and 80%–86% for PRECIS-2 (76/71% deferred).</div></div><div><h3>Conclusion</h3><div>Current LLMs alone appraised evidence worse than humans. Human–AI collaboration may reduce workload for the second human rater for the assessment of reporting (PRISMA) and methodological rigor (AMSTAR) but not for complex tasks such as PRECIS-2.</div></div>","PeriodicalId":51079,"journal":{"name":"Journal of Clinical Epidemiology","volume":"175 ","pages":"Article 111533"},"PeriodicalIF":7.3000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Benchmarking Human–AI collaboration for common evidence appraisal tools\",\"authors\":\"Tim Woelfle ,&nbsp;Julian Hirt ,&nbsp;Perrine Janiaud ,&nbsp;Ludwig Kappos ,&nbsp;John P.A. Ioannidis ,&nbsp;Lars G. Hemkens\",\"doi\":\"10.1016/j.jclinepi.2024.111533\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and Objective</h3><div>It is unknown whether large language models (LLMs) may facilitate time- and resource-intensive text-related processes in evidence appraisal. The objective was to quantify the agreement of LLMs with human consensus in appraisal of scientific reporting (Preferred Reporting Items for Systematic reviews and Meta-Analyses [PRISMA]) and methodological rigor (A MeaSurement Tool to Assess systematic Reviews [AMSTAR]) of systematic reviews and design of clinical trials (PRagmatic Explanatory Continuum Indicator Summary 2 [PRECIS-2]) and to identify areas where collaboration between humans and artificial intelligence (AI) would outperform the traditional consensus process of human raters in efficiency.</div></div><div><h3>Study Design and Setting</h3><div>Five LLMs (Claude-3-Opus, Claude-2, GPT-4, GPT-3.5, Mixtral-8x22B) assessed 112 systematic reviews applying the PRISMA and AMSTAR criteria and 56 randomized controlled trials applying PRECIS-2. We quantified the agreement between human consensus and (1) individual human raters; (2) individual LLMs; (3) combined LLMs approach; (4) human–AI collaboration. Ratings were marked as deferred (undecided) in case of inconsistency between combined LLMs or between the human rater and the LLM.</div></div><div><h3>Results</h3><div>Individual human rater accuracy was 89% for PRISMA and AMSTAR, and 75% for PRECIS-2. Individual LLM accuracy was ranging from 63% (GPT-3.5) to 70% (Claude-3-Opus) for PRISMA, 53% (GPT-3.5) to 74% (Claude-3-Opus) for AMSTAR, and 38% (GPT-4) to 55% (GPT-3.5) for PRECIS-2. Combined LLM ratings led to accuracies of 75%–88% for PRISMA (4%–74% deferred), 74%–89% for AMSTAR (6%–84% deferred), and 64%–79% for PRECIS-2 (29%–88% deferred). Human–AI collaboration resulted in the best accuracies from 89% to 96% for PRISMA (25/35% deferred), 91%–95% for AMSTAR (27/30% deferred), and 80%–86% for PRECIS-2 (76/71% deferred).</div></div><div><h3>Conclusion</h3><div>Current LLMs alone appraised evidence worse than humans. Human–AI collaboration may reduce workload for the second human rater for the assessment of reporting (PRISMA) and methodological rigor (AMSTAR) but not for complex tasks such as PRECIS-2.</div></div>\",\"PeriodicalId\":51079,\"journal\":{\"name\":\"Journal of Clinical Epidemiology\",\"volume\":\"175 \",\"pages\":\"Article 111533\"},\"PeriodicalIF\":7.3000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0895435624002890\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0895435624002890","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

背景:大语言模型(LLMs)是否能促进证据评估中与文本相关的时间和资源密集型流程尚不清楚:量化大型语言模型与人类共识在科学报告评估(PRISMA)和系统综述方法严谨性(AMSTAR)以及临床试验设计(PRECIS-2)方面的一致性。确定在哪些领域,人类与人工智能的合作将在效率上优于传统的人类评审员共识流程:设计:五位 LLM(Claude-3-Opus、Claude-2、GPT-4、GPT-3.5、Mixtral-8x22B)采用 PRISMA 和 AMSTAR 标准评估了 112 篇系统综述,并采用 PRECIS-2 评估了 56 项随机对照试验。我们量化了人类共识与 (1) 单个人类评分者;(2) 单个 LLMs;(3) LLMs 组合方法;(4) 人类与人工智能合作之间的一致性。在综合 LLMs 之间或人类评分者与 LLM 之间出现不一致时,评分被标记为推迟(未决定):PRISMA和AMSTAR的人类评分者个人准确率为89%,PRECIS-2为75%。PRISMA 的单个 LLM 准确率从 63% (GPT-3.5) 到 70% (Claude-3-Opus)不等,AMSTAR 的单个 LLM 准确率从 53% (GPT-3.5) 到 74% (Claude-3-Opus)不等,PRECIS-2 的单个 LLM 准确率从 38% (GPT-4) 到 55% (GPT-3.5)不等。综合 LLM 评级使 PRISMA 的准确率达到 75-88%(4-74% 延迟),AMSTAR 的准确率达到 74-89%(6-84% 延迟),PRECIS-2 的准确率达到 64-79%(29-88% 延迟)。人类与人工智能合作的最佳准确率为:PRISMA 89-96%(25/35%延迟),AMSTAR 91-95%(27/30%延迟),PRECIS-2 80-86%(76/71%延迟):结论:目前的 LLMs 对证据的单独评估不如人类。在评估报告(PRISMA)和方法论严谨性(AMSTAR)时,人类与人工智能的合作可以减轻第二位人类评审员的工作量,但在评估 PRECIS-2 等复杂任务时则无法减轻工作量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Benchmarking Human–AI collaboration for common evidence appraisal tools

Background and Objective

It is unknown whether large language models (LLMs) may facilitate time- and resource-intensive text-related processes in evidence appraisal. The objective was to quantify the agreement of LLMs with human consensus in appraisal of scientific reporting (Preferred Reporting Items for Systematic reviews and Meta-Analyses [PRISMA]) and methodological rigor (A MeaSurement Tool to Assess systematic Reviews [AMSTAR]) of systematic reviews and design of clinical trials (PRagmatic Explanatory Continuum Indicator Summary 2 [PRECIS-2]) and to identify areas where collaboration between humans and artificial intelligence (AI) would outperform the traditional consensus process of human raters in efficiency.

Study Design and Setting

Five LLMs (Claude-3-Opus, Claude-2, GPT-4, GPT-3.5, Mixtral-8x22B) assessed 112 systematic reviews applying the PRISMA and AMSTAR criteria and 56 randomized controlled trials applying PRECIS-2. We quantified the agreement between human consensus and (1) individual human raters; (2) individual LLMs; (3) combined LLMs approach; (4) human–AI collaboration. Ratings were marked as deferred (undecided) in case of inconsistency between combined LLMs or between the human rater and the LLM.

Results

Individual human rater accuracy was 89% for PRISMA and AMSTAR, and 75% for PRECIS-2. Individual LLM accuracy was ranging from 63% (GPT-3.5) to 70% (Claude-3-Opus) for PRISMA, 53% (GPT-3.5) to 74% (Claude-3-Opus) for AMSTAR, and 38% (GPT-4) to 55% (GPT-3.5) for PRECIS-2. Combined LLM ratings led to accuracies of 75%–88% for PRISMA (4%–74% deferred), 74%–89% for AMSTAR (6%–84% deferred), and 64%–79% for PRECIS-2 (29%–88% deferred). Human–AI collaboration resulted in the best accuracies from 89% to 96% for PRISMA (25/35% deferred), 91%–95% for AMSTAR (27/30% deferred), and 80%–86% for PRECIS-2 (76/71% deferred).

Conclusion

Current LLMs alone appraised evidence worse than humans. Human–AI collaboration may reduce workload for the second human rater for the assessment of reporting (PRISMA) and methodological rigor (AMSTAR) but not for complex tasks such as PRECIS-2.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
12.00
自引率
6.90%
发文量
320
审稿时长
44 days
期刊介绍: The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.
期刊最新文献
Key challenges in epidemiology: Embracing open science. Patient-reported outcomes and measures are under-utilised in advanced therapy medicinal products trials for orphan conditions. Research culture influences in health and biomedical research: Rapid scoping review and content analysis. Corrigendum to 'Avoiding searching for outcomes called for additional search strategies: a study of cochrane review searches' [Journal of Clinical Epidemiology, 149 (2022) 83-88]. A methodological review identified several options for utilizing registries for randomized controlled trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1